Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine

Pancreas

Volumn 37, Issue 4, 2008, Pages 405-410

  Nakai, Yousuke ^a,b   Isayama, Hiroyuki ^a   Kawabe, Takao ^a   Tsujino, Takeshi ^a   Yoshida, Haruhiko ^a   Sasaki, Takashi ^a   Tada, Minoru ^a   Arizumi, Toshihiko ^a   Yagioka, Hiroshi ^a   Kogure, Hirofumi ^a   Togawa, Osamu ^a   Ito, Yukiko ^a   Matsubara, Saburou ^a   Hirano, Kenji ^a   Sasahira, Naoki ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bile duct obstruction; Gemcitabine; Pancreatic cancer; Stents

Indexed keywords

GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; METAL;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BACTERIAL PERITONITIS; CANCER PATIENT; CANCER SURVIVAL; CHOLANGITIS; CHOLECYSTITIS; CLINICAL EVALUATION; COLITIS; COMPLICATION; CONTROLLED STUDY; DIARRHEA; EXPANDABLE METALLIC STENT; FEMALE; HEMOBILIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PANCREATITIS; PERFORMANCE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RASH; RETROSPECTIVE STUDY; SEPSIS; SOCIAL SUPPORT; STENT; STENT MIGRATION; STENT OCCLUSION; SUBPHRENIC ABSCESS; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS; VOMITING; BILIARY TRACT SURGERY; CHOLESTASIS; INFECTION; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PANCREAS TUMOR; PROSTHESIS; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BILIARY TRACT SURGICAL PROCEDURES; CHOLANGITIS; CHOLECYSTITIS; CHOLESTASIS; DEOXYCYTIDINE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; NEUTROPENIA; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149159821     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181706d93     Document Type: Article

References (23)

1. Davids PH, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340(8834-8835):1488-1492.
2. Knyrim K, Wagner HJ, Pausch J, et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25(3):207-212.
3. Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201(1):167-172.
4. Isayama H, Komatsu Y, Tsujino T, et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc. 2002;55(3):366-370.
5. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004; 53(5):729-734.
6. Nakai Y, Isayama H, Komatsu Y, et al. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc. 2005;62(5):742-748.
7. Kahaleh M, Tokar J, Conaway MR, et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc. 2005;61(4):528-533.
8. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403-2413.
9. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2(8550):57-62.
10. Okamoto T, Fujioka S, Yanagisawa S, et al. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc. 2006;63(6):792-796.
11. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383-393.
12. Colucci G, Giuliani F, Gebbia V, et al. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. Cancer. 2002; 94(4):902-910.
13. Louvet C, Labianca R, Hammel P, et al. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol. 2005;23(15):3509-3516.
14. Heinemann V, Quietzsch D, Gieseler F, et al. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol. 2006;24(24):3946-3952.
15. Lofts FJ, Evans TR, Mansi JL, et al. Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy? Eur J Cancer. 1997;33(2):209-213.
16. Mullen JT, Lee JH, Gomez HF, et al. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg. 2005; 9(8):1094-1104; discussion 104-105.
17. Wasan SM, Ross WA, Staerkel GA, et al. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol. 2005;100(9):2056-2061.
18. Ishii H, Okada S, Nose H, et al. Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy. Pancreas. 1996;12(3):267-271.
19. Cubiella J, Castells A, Fondevila C, et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol. 1999;94(5):1271-1278.
20. Ueno H, Okada S, Okusaka T, et al. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology. 2000;59(4):296-301.
21. Sezgin C, Karabulut B, Uslu R, et al. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors. Scand J Gastroenterol. 2005;40(12):1486-1492.
22. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg.WW 1988;75(12):1166-1168.
23. Andersen JR, Sorensen SM, Kruse A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989;30(8):1132-1135.